Diabetic Macular Edema Market Size, Share and Forecast 2026
Diabetic Macular Edema market is estimated to grow to USD XX billion by 2026.
(EMAILWIRE.COM, September 09, 2019 ) Market Overview:
Diabetic Macular Edema (DME) is the accumulation of fluid in the macula part of the retina due to leaking blood vessels.
Diabetic Macular Edema market is estimated to grow to USD XX billion by 2026.
Market Dynamics:
Increasing prevalence of diabetes is the prime factor driving the growth of Diabetic Macular Edema market. However, unfavorable reimbursement policies will restrict market growth.
Market Segmentation:
Diabetic Macular Edema market report segments the market by therapy type, product type, distribution channel.
By Therapy Type
• Anti-VEGF
• Corticosteroids
• Other Off-label Drugs
By Product Type
• Intravitreal Injections
• Intravitreal Implants
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Others
Geographical Analysis:
Regionally, the market is segmented into five major regions, namely:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Novartis
• Roche
• Allergan
• Hoffmann-La Roche Ltd.
• Regeneron Pharmaceuticals, Inc.
• Pfizer Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/diabetic-macular-edema-market
Download free sample: https://www.datamintelligence.com/download-sample/diabetic-macular-edema-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Diabetic Macular Edema (DME) is the accumulation of fluid in the macula part of the retina due to leaking blood vessels.
Diabetic Macular Edema market is estimated to grow to USD XX billion by 2026.
Market Dynamics:
Increasing prevalence of diabetes is the prime factor driving the growth of Diabetic Macular Edema market. However, unfavorable reimbursement policies will restrict market growth.
Market Segmentation:
Diabetic Macular Edema market report segments the market by therapy type, product type, distribution channel.
By Therapy Type
• Anti-VEGF
• Corticosteroids
• Other Off-label Drugs
By Product Type
• Intravitreal Injections
• Intravitreal Implants
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Others
Geographical Analysis:
Regionally, the market is segmented into five major regions, namely:
• North America
• South America
• Europe
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• Novartis
• Roche
• Allergan
• Hoffmann-La Roche Ltd.
• Regeneron Pharmaceuticals, Inc.
• Pfizer Inc.
• Others
View full report: https://www.datamintelligence.com/research-report/diabetic-macular-edema-market
Download free sample: https://www.datamintelligence.com/download-sample/diabetic-macular-edema-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results